FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

65831000036105: Hepasol (glycerophosphate calcium 88 mg / 10 mL + glycerophosphate ferric 21.75 mg / 10 mL + glycerophosphate manganese 2 mg / 10 mL + glycerophosphate potassium 10.61 mg / 10 mL + glycerophosphate sodium 10.61 mg / 10 mL + liver extract 38.67 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid: solution, 200 mL, bottle (containered trade product pack)

    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    260171000036119 Hepasol (glycerophosphate calcium 88 mg / 10 mL + glycerophosphate ferric 21.75 mg / 10 mL + glycerophosphate manganese 2 mg / 10 mL + glycerophosphate potassium 10.61 mg / 10 mL + glycerophosphate sodium 10.61 mg / 10 mL + liver extract 38.67 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid: solution, 200 mL, bottle (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    260181000036117 Hepasol oral liquid: solution, 200 mL, bottle en Synonym Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Hepasol (glycerophosphate calcium 88 mg / 10 mL + glycerophosphate ferric 21.75 mg / 10 mL + glycerophosphate manganese 2 mg / 10 mL + glycerophosphate potassium 10.61 mg / 10 mL + glycerophosphate sodium 10.61 mg / 10 mL + liver extract 38.67 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid: solution, 200 mL, bottle (containered trade product pack) Is a containered trade product pack false Inferred relationship Some
    Hepasol (glycerophosphate calcium 88 mg / 10 mL + glycerophosphate ferric 21.75 mg / 10 mL + glycerophosphate manganese 2 mg / 10 mL + glycerophosphate potassium 10.61 mg / 10 mL + glycerophosphate sodium 10.61 mg / 10 mL + liver extract 38.67 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid: solution, 200 mL, bottle (containered trade product pack) Is a Hepasol oral liquid: solution, 200 mL false Inferred relationship Some
    Hepasol (glycerophosphate calcium 88 mg / 10 mL + glycerophosphate ferric 21.75 mg / 10 mL + glycerophosphate manganese 2 mg / 10 mL + glycerophosphate potassium 10.61 mg / 10 mL + glycerophosphate sodium 10.61 mg / 10 mL + liver extract 38.67 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid: solution, 200 mL, bottle (containered trade product pack) has container type bottle false Inferred relationship Some
    Hepasol (glycerophosphate calcium 88 mg / 10 mL + glycerophosphate ferric 21.75 mg / 10 mL + glycerophosphate manganese 2 mg / 10 mL + glycerophosphate potassium 10.61 mg / 10 mL + glycerophosphate sodium 10.61 mg / 10 mL + liver extract 38.67 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid: solution, 200 mL, bottle (containered trade product pack) has TPUU Hepasol oral liquid: solution, 10 mL false Inferred relationship Some
    Hepasol (glycerophosphate calcium 88 mg / 10 mL + glycerophosphate ferric 21.75 mg / 10 mL + glycerophosphate manganese 2 mg / 10 mL + glycerophosphate potassium 10.61 mg / 10 mL + glycerophosphate sodium 10.61 mg / 10 mL + liver extract 38.67 mg / 10 mL + thiamine hydrochloride 1.19 mg / 10 mL) oral liquid: solution, 200 mL, bottle (containered trade product pack) has TP Hepasol false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start